Zhongnan Medical Journal Press

Home Results

A total of 10 result was found. Results that relate to AN Wei

Research progress in antibacterial modification of titanium implant surface

Published on New Medicine 2023,33(1):50-61.
5341 times 1536 times

Yong-Han WEI Yu-Jie SHI Wan-Qi PENG Wen-Zhong XIE Ling-Ling ZHANG Jun SHAO

Titanium implants Antibacterial modification Nanostructures Anti-adhesion Contact sterilization
Details
Observation of the therapeutic effect of Liuwei Dihuang decoction on thrombocytopenia of liver and kidney yin deficiency in hemodialysis patients

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1354-1361.
4366 times 1286 times

Rong CAO Hua-Juan WEI Shan-Shan SUN Na QIN Wei-Hua LIU Li-Yan SUN

Liuwei Dihuang decoction Hemodialysis Liver and kidney Yin deficiency Thrombocytopenia Clinical efficacy Platelet count
Details
A case of pharmaceutical caring for psychiatric abnormalities associated with low dose regorafenib in the treatment of advanced soft tissue sarcoma

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):466-470.
5023 times 1157 times

FANG Shasha AN Wei TIAN Ying YU Qianqian ZHANG Mingwei CHEN Min

Regorafenib Soft tissue sarcoma Mental disorders Drug adverse reactions Pharmaceutical care
Details
Efficacy and safety of trastuzumab deruxtecan in the treatment of breast cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):539-548.
4288 times 1160 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai LUAN Wei

Trastuzumab deruxtecan Antibody drug conjugates Breast cancer Efficacy Safety Meta-analysis Randomized controlled trial
Details
Status of etiology and pathogenesis of lumbar ligamentum flavum hypertrophy

Published on Journal of Mathematical Medicine 2024,37(7):534-542.
5019 times 1102 times

MAO Jianwei [MW ZHANG Weiping YANG Chen LI Jingzhou QIANG Tianming DUAN Wenshuai

Ligamentum flavum hypertrophy Fibrosis Etiology Pathogenesis
Details
Signal mining and analysis of adverse drug events related to trastuzumab emtansine and trastuzumab deruxtecan based on JADER database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(8):841-850.
4717 times 996 times

PAN Weiping YAN Shaowei LI Binghuang CAO Yu XU Wentan

Trastuzumab emtansine Trastuzumab deruxtecan Adverse drug event JADER database Pharmacovigilance Antibody-drug conjugates
Details
Construction of a prediction model for moderate to severe perimenopausal syndrome based on machine learning algorithms

Published on New Medicine 2024,34(8):871-879.
4021 times 1102 times

ZHANG Min GU Tingting GUAN Wei LIU Xiangxiang SHI Junyao

Perimenopausal syndrome Perimenopausal women Machine learning Prediction
Details
Evaluation of potentially inappropriate medication of novel oral anticoagulant in elderly patients with non-valvular atrial fibrillation

Published on Chinese Journal of Pharmacoepidemiology 2025,34(1):21-26.
4005 times 515 times

WANG Yan TIAN Weiwei ZHU Haibin YU Zicheng

Novel oral anticoagulants Elderly patient Non-valvular atrial fibrillation Potential inappropriate medication
Details
Practice and reflection on the compliance construction of WHO pharmaceutical microbiology quality control laboratory

Published on Frontiers in Pharmaceutical Sciences 2025,29(5):894-900.
1897 times 261 times

PAN Weijing PENG Ming WU Xiaoluan QIN Feng GU Songqing

World Health Organization Pharmaceutical microbiology Quality control laboratory Compliance construction
Details
Clinical progress of cadonilimab in the treatment of malignant tumor

Published on New Medicine 2025,35(6):708-715.
1818 times 423 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai WANG Yuchao HE Jing LUAN Wei

Cadonilimab Bispecific antibody Immunotherapy Tumors
Details